|
| Lisa M Schwartz | a Dartmouth Institute for Health Policy and Clinical Practice |
| Gerald J Dal Pan | Center for Drug Evaluation and Research |
| Aaron S Kesselheim | Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School |